HomeNewsIndiaParliamentary panel on IT to meet on June 17 to discuss Aarogya Setu app, data security

Parliamentary panel on IT to meet on June 17 to discuss Aarogya Setu app, data security

According to sources, the meeting of the Parliamentary Standing Committee on IT, headed by senior Congress leader Shashi Tharoor, was to take place on June 10 but was postponed to June 17 as there was no final decision on whether the meeting could be held via video conferencing.

June 05, 2020 / 21:53 IST
Story continues below Advertisement

Parliamentary panel on Information Technology is scheduled to hold a meeting on June 17 along with the officials of the Information and Technology Ministry to get a briefing on the government's Aarogya Setu application and its related issues of data security and privacy of citizens, sources said on Friday.

According to sources, the meeting of the Parliamentary Standing Committee on IT, headed by senior Congress leader Shashi Tharoor, was to take place on June 10 but was postponed to June 17 as there was no final decision on whether the meeting could be held via video conferencing.

Story continues below Advertisement

During the meeting, members are also likely to call representatives of the Information and broadcasting ministry to discuss the subject of ethical standards in media coverage, sources said. However,they did not elaborate.

The Ministry of Electronics and Information Technology officials are also scheduled to be called to brief the members on the government's coronavirus-tracking Aarogya Setu application and issues of data security and privacy of citizens, sources said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show